State-of-the-art technology for cancer therapy.<\/mark><\/h1><\/div><\/div><\/div><\/div><\/div>For the treatment of <\/span> Tomorrow.<\/span><\/span> <\/span><\/h2><\/div><\/div><\/div><\/span> Sustainable<\/span><\/span> <\/span><\/h3><\/div>We are scaling up the production of radionuclides for cancer therapy (radioligand therapy). To do this, we use particle accelerators, thus using electricity instead of research or nuclear reactors, and recycle our starting material.<\/p>\n<\/div><\/div><\/div><\/div><\/i><\/div><\/div><\/span> Safe<\/span><\/span> <\/span><\/h3><\/div>Our accelerators are in a safe radiation protection environment and pose no safety risk. Our processes allow GMP products with very high levels of purity and thus protect patients.<\/p>\n<\/div><\/div><\/div><\/div><\/i><\/div><\/div><\/span> Accessible<\/span><\/span> <\/span><\/h3><\/div>LinaThera makes radionuclides for radioligand therapy accessible on a large scale – for research, development and, above all, for reliable patient care.<\/p>\n<\/div><\/div><\/div><\/div><\/i><\/div><\/div><\/div><\/div><\/span> Feasibility study<\/span><\/span> <\/span><\/h2><\/div><\/div><\/div>![](\"https:\/\/linathera.com\/wp-content\/uploads\/51b-02003_Broschuere_LT_Web_1-0.webp\" "\\"51b-02003_Broschuere_LT_Web_1-0\\"")
<\/span><\/div><\/div><\/div>Sustainable healthcare as a driver of innovation for northern Bavaria.<\/h3><\/div>We would like to thank the district of Forchheim and Medical Valley Forchheim for their support with this feasibility study. It is a joint effort, the result of a close exchange between research, industry and our partners. The study is intended to appeal to decision-makers from politics and society and lay the foundations for establishing Northern Bavaria as a region of progress for innovative and responsible cancer therapies in nuclear medicine.<\/p>\n<\/div>
<\/i>Brochure (de)<\/span><\/a><\/div><\/i>Long version (de)<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>We make modern cancer therapy accessible through sustainable, safe production of radioisotopes in a stand-alone facility – expandable and replicable<\/mark>.<\/h3><\/div><\/div><\/div>![](\"https:\/\/linathera.com\/wp-content\/uploads\/51b-02003_Gebaeude_0-3.webp\" "\\"51b-02003_Geba\u0308ude_0-3\\"")
<\/span><\/div><\/div><\/div>![](\"https:\/\/linathera.com\/wp-content\/uploads\/51b-02003_Gebaeude_0-2.webp\" "\\"51b-02003_Geba\u0308ude_0-2\\"")
<\/span><\/div><\/div><\/div>![](\"https:\/\/linathera.com\/wp-content\/uploads\/51b-02003_Gebaeude_0-1.webp\" "\\"51b-02003_Geba\u0308ude_0-1\\"")
<\/span><\/div><\/div><\/div><\/div><\/div>2021<\/h2><\/div>Founding idea<\/p>\n<\/div><\/div><\/li>\n
2022<\/h2><\/div>Foundation<\/p>\n<\/div><\/div><\/li>\n
2023<\/h2><\/div>Development team, company, cooperations<\/p>\n<\/div><\/div><\/li>\n
2024<\/h2><\/div>Location in Hallerndorf secured<\/p>\n<\/div><\/div><\/li>\n
2025<\/h2><\/div>Building planning<\/p>\n<\/div><\/div><\/li>\n
2028<\/h2><\/div>Commercial production<\/p>\n<\/div><\/div><\/li>\n<\/ul><\/div><\/div><\/div><\/div><\/div>
<\/span> Our partners<\/span><\/span> <\/span><\/h2><\/div><\/div><\/div><\/div><\/div>![](\"https:\/\/linathera.com\/wp-content\/uploads\/Logo-Main-Dark@0.5x.webp\")
<\/a><\/span><\/div><\/div><\/div>\n![](\"https:\/\/linathera.com\/wp-content\/uploads\/medical-valley-center-forchheim-sw.png\")
<\/a><\/span><\/div><\/div><\/div>\n![](\"https:\/\/linathera.com\/wp-content\/uploads\/nuclidium-sw.png\")
<\/a><\/span><\/div><\/div><\/div>\n![](\"https:\/\/linathera.com\/wp-content\/uploads\/program51-sw.png\")
<\/a><\/span><\/div><\/div><\/div>\n![](\"https:\/\/linathera.com\/wp-content\/uploads\/uniklinikum-erlangen-sw.png\")
<\/a><\/span><\/div><\/div><\/div>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/span> Press & News<\/span><\/span> <\/span><\/h2><\/div><\/div><\/div><\/div><\/div>- <\/span><\/a><\/span>
Medical Valley Center Forchheim: Das Muster-Start-Up Lina Thera<\/h4><\/div>26.05.2025<\/p>\n<\/div><\/div><\/div>
TV Oberfranken<\/p>\n<\/div><\/i><\/div><\/div><\/div><\/div><\/li>\n- <\/span><\/a><\/span>
Einmalig in Europa: In Hallerndorf entstehen radioaktive Teilchen f\u00fcr Krebspatienten<\/h4><\/div>28.07.2025<\/p>\n<\/div><\/div><\/div>
N\u00fcrnberger Nachrichten<\/p>\n<\/div><\/i><\/div><\/div><\/div><\/div><\/li>\n- <\/span><\/a><\/span>
Making radioligand therapy accessible with copper isotopes<\/h4><\/div>01.10.2024<\/p>\n<\/div><\/div><\/div>
Pro Concept<\/p>\n<\/div><\/i><\/div><\/div><\/div><\/div><\/li>\n- <\/span><\/a><\/span>
For the treatment of <\/span> Tomorrow.<\/span><\/span> <\/span><\/h2><\/div><\/div><\/div><\/span> Sustainable<\/span><\/span> <\/span><\/h3><\/div>We are scaling up the production of radionuclides for cancer therapy (radioligand therapy). To do this, we use particle accelerators, thus using electricity instead of research or nuclear reactors, and recycle our starting material.<\/p>\n<\/div><\/div><\/div><\/div><\/i><\/div><\/div><\/span> Safe<\/span><\/span> <\/span><\/h3><\/div>Our accelerators are in a safe radiation protection environment and pose no safety risk. Our processes allow GMP products with very high levels of purity and thus protect patients.<\/p>\n<\/div><\/div><\/div><\/div><\/i><\/div><\/div><\/span> Accessible<\/span><\/span> <\/span><\/h3><\/div>LinaThera makes radionuclides for radioligand therapy accessible on a large scale – for research, development and, above all, for reliable patient care.<\/p>\n<\/div><\/div><\/div><\/div><\/i><\/div><\/div><\/div><\/div><\/span> Feasibility study<\/span><\/span> <\/span><\/h2><\/div><\/div><\/div><\/span><\/div><\/div><\/div>Sustainable healthcare as a driver of innovation for northern Bavaria.<\/h3><\/div>We would like to thank the district of Forchheim and Medical Valley Forchheim for their support with this feasibility study. It is a joint effort, the result of a close exchange between research, industry and our partners. The study is intended to appeal to decision-makers from politics and society and lay the foundations for establishing Northern Bavaria as a region of progress for innovative and responsible cancer therapies in nuclear medicine.<\/p>\n<\/div>
<\/i>Brochure (de)<\/span><\/a><\/div><\/i>Long version (de)<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>We make modern cancer therapy accessible through sustainable, safe production of radioisotopes in a stand-alone facility – expandable and replicable<\/mark>.<\/h3><\/div><\/div><\/div><\/span><\/div><\/div><\/div><\/span><\/div><\/div><\/div><\/span><\/div><\/div><\/div><\/div><\/div>2021<\/h2><\/div>Founding idea<\/p>\n<\/div><\/div><\/li>\n
2022<\/h2><\/div>Foundation<\/p>\n<\/div><\/div><\/li>\n
2023<\/h2><\/div>Development team, company, cooperations<\/p>\n<\/div><\/div><\/li>\n
2024<\/h2><\/div>Location in Hallerndorf secured<\/p>\n<\/div><\/div><\/li>\n
2025<\/h2><\/div>Building planning<\/p>\n<\/div><\/div><\/li>\n
2028<\/h2><\/div>Commercial production<\/p>\n<\/div><\/div><\/li>\n<\/ul><\/div><\/div><\/div><\/div><\/div>
<\/span> Our partners<\/span><\/span> <\/span><\/h2><\/div><\/div><\/div><\/div><\/div><\/a><\/span><\/div><\/div><\/div>\n<\/a><\/span><\/div><\/div><\/div>\n<\/a><\/span><\/div><\/div><\/div>\n<\/a><\/span><\/div><\/div><\/div>\n<\/a><\/span><\/div><\/div><\/div>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/span> Press & News<\/span><\/span> <\/span><\/h2><\/div><\/div><\/div><\/div><\/div>- <\/span><\/a><\/span>
Medical Valley Center Forchheim: Das Muster-Start-Up Lina Thera<\/h4><\/div>26.05.2025<\/p>\n<\/div><\/div><\/div>
TV Oberfranken<\/p>\n<\/div><\/i><\/div><\/div><\/div><\/div><\/li>\n- <\/span><\/a><\/span>
Einmalig in Europa: In Hallerndorf entstehen radioaktive Teilchen f\u00fcr Krebspatienten<\/h4><\/div>28.07.2025<\/p>\n<\/div><\/div><\/div>
N\u00fcrnberger Nachrichten<\/p>\n<\/div><\/i><\/div><\/div><\/div><\/div><\/li>\n- <\/span><\/a><\/span>
Making radioligand therapy accessible with copper isotopes<\/h4><\/div>01.10.2024<\/p>\n<\/div><\/div><\/div>
Pro Concept<\/p>\n<\/div><\/i><\/div><\/div><\/div><\/div><\/li>\n- <\/span><\/a><\/span>
<\/span> Sustainable<\/span><\/span> <\/span><\/h3><\/div>We are scaling up the production of radionuclides for cancer therapy (radioligand therapy). To do this, we use particle accelerators, thus using electricity instead of research or nuclear reactors, and recycle our starting material.<\/p>\n<\/div><\/div><\/div><\/div><\/i><\/div><\/div><\/span> Safe<\/span><\/span> <\/span><\/h3><\/div>Our accelerators are in a safe radiation protection environment and pose no safety risk. Our processes allow GMP products with very high levels of purity and thus protect patients.<\/p>\n<\/div><\/div><\/div><\/div><\/i><\/div><\/div><\/span> Accessible<\/span><\/span> <\/span><\/h3><\/div>LinaThera makes radionuclides for radioligand therapy accessible on a large scale – for research, development and, above all, for reliable patient care.<\/p>\n<\/div><\/div><\/div><\/div><\/i><\/div><\/div><\/div><\/div><\/span> Feasibility study<\/span><\/span> <\/span><\/h2><\/div><\/div><\/div><\/span><\/div><\/div><\/div>Sustainable healthcare as a driver of innovation for northern Bavaria.<\/h3><\/div>We would like to thank the district of Forchheim and Medical Valley Forchheim for their support with this feasibility study. It is a joint effort, the result of a close exchange between research, industry and our partners. The study is intended to appeal to decision-makers from politics and society and lay the foundations for establishing Northern Bavaria as a region of progress for innovative and responsible cancer therapies in nuclear medicine.<\/p>\n<\/div>
<\/i>Brochure (de)<\/span><\/a><\/div><\/i>Long version (de)<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>We make modern cancer therapy accessible through sustainable, safe production of radioisotopes in a stand-alone facility – expandable and replicable<\/mark>.<\/h3><\/div><\/div><\/div><\/span><\/div><\/div><\/div><\/span><\/div><\/div><\/div><\/span><\/div><\/div><\/div><\/div><\/div>2021<\/h2><\/div>Founding idea<\/p>\n<\/div><\/div><\/li>\n
2022<\/h2><\/div>Foundation<\/p>\n<\/div><\/div><\/li>\n
2023<\/h2><\/div>Development team, company, cooperations<\/p>\n<\/div><\/div><\/li>\n
2024<\/h2><\/div>Location in Hallerndorf secured<\/p>\n<\/div><\/div><\/li>\n
2025<\/h2><\/div>Building planning<\/p>\n<\/div><\/div><\/li>\n
2028<\/h2><\/div>Commercial production<\/p>\n<\/div><\/div><\/li>\n<\/ul><\/div><\/div><\/div><\/div><\/div>
<\/span> Our partners<\/span><\/span> <\/span><\/h2><\/div><\/div><\/div><\/div><\/div><\/a><\/span><\/div><\/div><\/div>\n<\/a><\/span><\/div><\/div><\/div>\n<\/a><\/span><\/div><\/div><\/div>\n<\/a><\/span><\/div><\/div><\/div>\n<\/a><\/span><\/div><\/div><\/div>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/span> Press & News<\/span><\/span> <\/span><\/h2><\/div><\/div><\/div><\/div><\/div>- <\/span><\/a><\/span>
Medical Valley Center Forchheim: Das Muster-Start-Up Lina Thera<\/h4><\/div>26.05.2025<\/p>\n<\/div><\/div><\/div>
TV Oberfranken<\/p>\n<\/div><\/i><\/div><\/div><\/div><\/div><\/li>\n- <\/span><\/a><\/span>
Einmalig in Europa: In Hallerndorf entstehen radioaktive Teilchen f\u00fcr Krebspatienten<\/h4><\/div>28.07.2025<\/p>\n<\/div><\/div><\/div>
N\u00fcrnberger Nachrichten<\/p>\n<\/div><\/i><\/div><\/div><\/div><\/div><\/li>\n- <\/span><\/a><\/span>
Making radioligand therapy accessible with copper isotopes<\/h4><\/div>01.10.2024<\/p>\n<\/div><\/div><\/div>
Pro Concept<\/p>\n<\/div><\/i><\/div><\/div><\/div><\/div><\/li>\n- <\/span><\/a><\/span>
We are scaling up the production of radionuclides for cancer therapy (radioligand therapy). To do this, we use particle accelerators, thus using electricity instead of research or nuclear reactors, and recycle our starting material.<\/p>\n<\/div><\/div><\/div><\/div><\/i><\/div><\/div> Our accelerators are in a safe radiation protection environment and pose no safety risk. Our processes allow GMP products with very high levels of purity and thus protect patients.<\/p>\n<\/div><\/div><\/div><\/div><\/i><\/div><\/div> LinaThera makes radionuclides for radioligand therapy accessible on a large scale – for research, development and, above all, for reliable patient care.<\/p>\n<\/div><\/div><\/div><\/div><\/i><\/div><\/div><\/div><\/div> We would like to thank the district of Forchheim and Medical Valley Forchheim for their support with this feasibility study. It is a joint effort, the result of a close exchange between research, industry and our partners. The study is intended to appeal to decision-makers from politics and society and lay the foundations for establishing Northern Bavaria as a region of progress for innovative and responsible cancer therapies in nuclear medicine.<\/p>\n<\/div> We make modern cancer therapy accessible through sustainable, safe production of radioisotopes in a stand-alone facility – expandable and replicable<\/mark>.<\/h3><\/div><\/div><\/div> Founding idea<\/p>\n<\/div><\/div><\/li>\n Foundation<\/p>\n<\/div><\/div><\/li>\n Development team, company, cooperations<\/p>\n<\/div><\/div><\/li>\n Location in Hallerndorf secured<\/p>\n<\/div><\/div><\/li>\n Building planning<\/p>\n<\/div><\/div><\/li>\n Commercial production<\/p>\n<\/div><\/div><\/li>\n<\/ul><\/div><\/div><\/div><\/div><\/div> 26.05.2025<\/p>\n<\/div><\/div><\/div> TV Oberfranken<\/p>\n<\/div><\/i><\/div><\/div><\/div><\/div><\/li>\n 28.07.2025<\/p>\n<\/div><\/div><\/div> N\u00fcrnberger Nachrichten<\/p>\n<\/div><\/i><\/div><\/div><\/div><\/div><\/li>\n 01.10.2024<\/p>\n<\/div><\/div><\/div> Pro Concept<\/p>\n<\/div><\/i><\/div><\/div><\/div><\/div><\/li>\n<\/span> Safe<\/span><\/span> <\/span><\/h3><\/div>
<\/span> Accessible<\/span><\/span> <\/span><\/h3><\/div>
<\/span> Feasibility study<\/span><\/span> <\/span><\/h2><\/div><\/div><\/div>
<\/span><\/div><\/div><\/div>Sustainable healthcare as a driver of innovation for northern Bavaria.<\/h3><\/div>
<\/span><\/div><\/div><\/div><\/span><\/div><\/div><\/div><\/span><\/div><\/div><\/div><\/div><\/div>2021<\/h2><\/div>
2022<\/h2><\/div>
2023<\/h2><\/div>
2024<\/h2><\/div>
2025<\/h2><\/div>
2028<\/h2><\/div>
<\/span> Our partners<\/span><\/span> <\/span><\/h2><\/div><\/div><\/div><\/div><\/div>
<\/a><\/span><\/div><\/div><\/div>\n<\/a><\/span><\/div><\/div><\/div>\n<\/a><\/span><\/div><\/div><\/div>\n<\/a><\/span><\/div><\/div><\/div>\n<\/a><\/span><\/div><\/div><\/div>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/span> Press & News<\/span><\/span> <\/span><\/h2><\/div><\/div><\/div><\/div><\/div>
Medical Valley Center Forchheim: Das Muster-Start-Up Lina Thera<\/h4><\/div>
Einmalig in Europa: In Hallerndorf entstehen radioaktive Teilchen f\u00fcr Krebspatienten<\/h4><\/div>
Making radioligand therapy accessible with copper isotopes<\/h4><\/div>